APA (7th ed.) Citation

Raymakers, A. J. N., Cameron, D., Tyldesley, S., & Regier, D. A. (2021). Cost-Effectiveness Analysis of Stereotactic Ablative Body Radiotherapy for the Treatment of Oligometastatic Tumors versus Standard of Care. Current Oncology, 28(3), 1857. https://doi.org/10.3390/curroncol28030172

Chicago Style (17th ed.) Citation

Raymakers, Adam J. N., David Cameron, Scott Tyldesley, and Dean A. Regier. "Cost-Effectiveness Analysis of Stereotactic Ablative Body Radiotherapy for the Treatment of Oligometastatic Tumors Versus Standard of Care." Current Oncology 28, no. 3 (2021): 1857. https://doi.org/10.3390/curroncol28030172.

MLA (9th ed.) Citation

Raymakers, Adam J. N., et al. "Cost-Effectiveness Analysis of Stereotactic Ablative Body Radiotherapy for the Treatment of Oligometastatic Tumors Versus Standard of Care." Current Oncology, vol. 28, no. 3, 2021, p. 1857, https://doi.org/10.3390/curroncol28030172.